Seres Therapeutics, Inc. (MCRB) vs OneMedNet Corporation (ONMD)

A side-by-side comparison of Seres Therapeutics, Inc. and OneMedNet Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MCRB vs ONMD

growth of $100 · dividends reinvested · last 5y
MCRB -99.4% (-64.0%/yr)ONMD -94.8% (-44.7%/yr)ONMD compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$1$5
MCRB ONMD

MCRB vs ONMD: by the numbers

  • •ONMD is the larger company ($29M vs $28M market cap).
  • •Both run net losses; ONMD's is the smaller (-584.20% vs -1192.94% net margin).
  • •ONMD grew revenue faster over the past five years (10.53% vs -42.51% CAGR).

Metrics side by side

Valuation

MetricMCRBONMD
P/S ratio14.6320.03
P/B ratio0.80N/A

Profitability

MetricMCRBONMD
Gross margin-423.83%-37.01%
Operating margin-11910.14%-711.33%
Net margin-1192.94%-584.20%
ROE-65.05%N/A
ROIC-103.04%N/A

Growth (annualized)

MetricMCRBONMD
Revenue CAGR (5Y)-42.51%10.53%
Total return CAGR (5Y)-53.37%-44.89%

Frequently asked

Which has grown faster, MCRB or ONMD?
Over the past five years, ONMD grew revenue faster — MCRB at a -42.51% CAGR versus ONMD at 10.53%.
How have MCRB and ONMD total returns compared?
Over the past 5 years, MCRB delivered -53.37% and ONMD delivered -44.89% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.